Enhancement Drugs and the Athlete

Neurologic Clinics

Volumn 26, Issue 1, 2008, Pages 149-167

  Botrè, Francesco ^a,b   Pavan, Antonio ^b  

^a Laboratorio Antidoping   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANABOLIC AGENT; ANDROGEN; ANDROSTENEDIONE; ANTIESTROGEN; CANNABINOID; CANNABIS; CLENBUTEROL; COCAINE; DIURETIC AGENT; EPITESTOSTERONE; FORMOTEROL; GONADOTROPIN; HUMAN GROWTH HORMONE; INSULIN; METHYLTESTOSTERONE; MORPHINE; MYOSTATIN; NANDROLONE; OPIATE; PRASTERONE; PROBENECID; SALBUTAMOL; SALMETEROL; SOMATOMEDIN; STANOZOLOL; STEROID 5ALPHA REDUCTASE; STRYCHNINE; TERBUTALINE; TESTOSTERONE;

AGGRESSIVENESS; ALERTNESS; ATHLETE; BEHAVIOR CHANGE; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CONSCIOUSNESS LEVEL; DOPING; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG EFFECT; ENDURANCE; FOLLICULITIS; FURUNCULOSIS; GEOGRAPHIC DISTRIBUTION; HEADACHE; HEALTH HAZARD; HEALTH PROGRAM; HUMAN; HYPERTENSION; LIBIDO; LIVER FUNCTION; MENTAL DISEASE; MEXICO; MOOD CHANGE; MOTOR PERFORMANCE; MUSCLE STRENGTH; NERVOUSNESS; NUTRITIONAL ASSESSMENT; OFF LABEL DRUG USE; OILY SKIN; OXYGEN TRANSPORT; PHYSICAL PERFORMANCE; POLICY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEBORRHEA; SPORT; WATER RETENTION;

ANABOLIC AGENTS; HUMANS; LABORATORIES; MOTOR ACTIVITY; SPORTS; SUBSTANCE-RELATED DISORDERS; WORLD HEALTH ORGANIZATION;

EID: 39449084387     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2007.12.003     Document Type: Review

References (30)

1. Zerbini M. Alle Fonti del Doping. Fortune e prospettive di un tema storico-religioso (2001), "L'Erma" di Bretschneider, Roma (Italy) [in Italian]
2. In: Christopoulos G.A. (Ed). The Olympic games in ancient Greece (2003), Ekdotike Hellados S.A., Athens (Greece)
3. Yalouris N. Origin and history of the games. In: Christopoulos G.A. (Ed). The Olympic games in ancient Greece (2003), Ekdotike Hellados S.A., Athens (Greece) 88-93
4. Kyrkos B. The development of sport in Hellenistic and Roman Periods. In: Christopoulos G.A. (Ed). The Olympic games in Ancient Greece (2003), Ekdotike Hellados S.A., Athens (Greece) 289-300
5. Wagner J.C. Enhancement of athletic performance with drugs. An overview. Sports Med 12 (1991) 250-265
6. Le Mondenard J.P. Dopage aux jeux olympiques (1996), Editions Amphora SA, Condé-Sur-Noireau (France) [in French]
7. Guezennec C.Y. Doping: effectiveness, consequences, prevention. Ann Endocrinol (Paris) 62 (2001) 33-41
8. The World Anti-Doping Code. World anti-doping agency. Montreal (Canada). 2003. Available at: www.wada-ama.org. Accessed October 31, 2007.
9. The World Anti-Doping Code. The 2008 prohibited list international standard. World Anti-doping Agency. Montreal (Canada). 2007. Available at: www.wada-ama.org. Accessed October 31, 2007.
10. Botrè F. Drugs of abuse and abuse of drugs in sportsmen: the role of in vitro methods to study effect and mechanism. Toxicol In Vitro 17 (2003) 509-513
11. Donohoe T., and Johnson N. Foul play? Drug abuse in sport (1986), Blackwell, Oxford (United Kingdom)
12. Wadler G.I., and Hainline B. Drugs and the athlete (1989), FA Davis Company, Philadelphia
13. Cowan D.A., and Kicman A.T. Doping in sport: misuse, analytical tests, and legal aspects. Clin Chem 43 (1997) 1110-1113
14. Segura J. Sports. In: Karch S.B. (Ed). Drug abuse handbook (1998), CRC Press, Boca Raton (USA) 641-726
15. In: Peters C., Schulz T., and Michna H. (Eds). Biochemical side effects of doping (2001), Sport & Büch Strauss, Köln (Germany)
16. Botrè F. Classi di sostanze e metodi doping. Schede riassuntive. Il CONI contro il doping. 2nd edition (2001), National Italian Olympic Committee, Rome (Italy) 19-37 [in Italian]
17. Menthéour E., and Blanchard C. Secret Défonce. Ma vérité sur le dopage (1999), J-C Lattès, Paris [in French]
18. Catlin D.H., Ahrens B.D., and Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. Rapid Commun Mass Spectrom 16 (2002) 1273-1275
19. Catlin D.H., Sekera M.H., Ahrens B.D., et al. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom 18 (2004) 1245-1249
20. Sekera M.H., Ahrens B.D., Chang Y.C., et al. Another designer steroid: discovery, synthesis, and detection of 'madol' in urine. Rapid Commun Mass Spectrom 19 (2005) 781-784
21. Malvey T.C., and Armsey II T.D. Tetrahydrogestrinone: the discovery of a designer steroid. Curr Sports Med Rep 4 (2005) 227-230
22. Georgakopoulos C., Vonaparti A., Stamou M., et al. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Commun Mass Spectrom 21 (2007) 2439-2446
23. Thevis M., Geyer H., Mareck U., et al. Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. J Mass Spectrom 40 (2005) 955-962
24. Mazzarino M, Turi S, Botrè F. A screening method for the detection of synthetic glucocorticoids in human urine by liquid chromatography-mass spectrometry based on class characteristic fragmentation pathways. Anal Bioanal Chem, in press.
25. Botrè F. I controlli antidoping nel terzo millennio: mai più sostanze 'invisibili'?. Med Sport 60 (2007) 119-131 [in Italian]
26. Botrè F., and Tranquilli C. Uso e diffusione degli integratori in Italia: opinioni a confronto. Med Sport 54 (2001) 263-274 [in Italian]
27. Caprino L., Braganò M.C., and Botrè F. Gli integratori fitoterapici nello sport: uso ed abuso. Ann Ist Super Sanita 41 (2005) 35-38 [in Italian]
28. Pipe A., and Ayotte C. Nutritional supplements and doping. Clin J Sport Med 12 (2002) 245-249
29. Geyer H., Parr M.K., Mareck U., et al. Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids-results of an international study. Int J Sports Med 25 (2004) 124-129
30. Spitzer G. Doping with children. In: Peters C., Schulz T., and Michna H. (Eds). Biochemical side effects of doping (2001), Sport & Büch Strauss, Köln (Germany) 127-139